634 results
Outcomes following transcatheter and percutaneous mitral valve repair
21 Nov 2021 – From PCR London Valves 2021
CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
Mitral valve disease: state-of-the-art
21 Nov 2021 – From PCR London Valves 2021
Did you ever wonder what an expert surgeon can achieve today in mitral repair? Have you ever wondered when to treat an asymptomatic patient with severe mitral regurgitation? These are some of the questions this session from PCR London Valves 2021 will try to answer.
Transcatheter mitral interventions: the future
21 Nov 2021 – From PCR London Valves 2021
What could be the future of transcatheter mitral valve intervention? Will it be repair or replacement? What are the current limitations? Find parts of the answers to these questions, and many others, in this session shot during the PCR LV 2021 Congress.
Mitral valve disease: guidelines and beyond
21 Nov 2021 – From PCR London Valves 2021
In this session from PCR London Valves 2021 dedicated to the new guidelines relating to the management of mitral valve disease, discover how to apply them in your everyday clinical practice to the care of your patients through presentations, interviews, heart team discussions, a live case...
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Role of fusion imaging for mitral valve repair
08 Oct 2021 – From AICT-AsiaPCR 2021
If you wish to know more about the concept of real-time fusion imaging of echocardiography and fluoroscopy, this session is for you: find out more about the use of fusion imaging and learn how to use this process in the management of procedures involving mitral valves.
Abstracts on mitral valve repair
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover two abstracts on mitral valve repair, and learn more about the outcomes of aortic and tricuspid regurgitation after percutaneous mitral commissurotomy.
